Although approximately one million cardiac arrests occur every year in the USA and Europe, cardiac arrest remains a clinical condition still characterized by poor prognosis. One possible explanation may be the fact that although 70% of cardiac arrests take place in out-of-hospital settings, the majority of the victims do not receive basic life support (BLS) prior to the arrival of emergency medical services (EMS). Survival of out-of-hospital cardiac arrest victims strongly depends on prompt cardiopulmonary resuscitation (CPR). Survival rates will only improve, if delay time until initiation of CPR is kept to an absolute minimum. Good quality CPR, with an emphasis on chest compressions is a key component for the victims survival. Drugs play a secondary role in the treatment of these patients. This book presents the latest research in drug therapy in CPR.
Preface; Adrenaline in cardiac arrest; Vasopressin in cardiac arrest; Atropine in cardiac arrest; Amiodarone, Magnesium & Calcium in cardiac arrest; Anti-ischemic therapy in acute coronary Syndromes; Anti-thrombotic therapy in acute coronary syndromes-Anticoagulants; Anti-thrombotic therapy in acute coronary syndromes-Antiplatelets; Beta-blockade in the treatment of periarrest arrhythmias & cardiac arrest; Nitroglycerin in the emergency setting; Adenosine:: Advanced pharmacology, basic research & clinical aspects; Inotropes & vasopressors in post-resuscitation care; Drugs in neonatal resuscitation; Index.
Komentarze (0)
Chwilowo nie możesz polubić tej opinii
Zgłoś komentarz
Czy jesteś pewien, że chcesz zgłosić ten komentarz?
Zgłoszenie wysłane
Twój komentarz został wysłany i będzie widoczny po zatwierdzeniu przez moderatora.